Skip to main content

Health and Medicine

Team finds potent antibodies against three Ebola viruses

Jul. 19, 2018—Researchers led by James Crowe Jr. are a step closer to developing a broadly effective antibody treatment against the three major Ebola viruses that cause lethal disease in humans. The hope is that the antibodies — like heat-seeking missiles — would seek out and destroy the viruses before they can wreak havoc in the body.

Read more


Study reveals opioid patients face multiple barriers to treatment

Jul. 12, 2018—In areas of the country disproportionately affected by the opioid crisis, treatment programs are less likely to accept patients paying through insurance of any type or accept pregnant women, a new Vanderbilt study found.

Read more


Team explores diabetes drug’s ability to treat RSV infection

Jul. 12, 2018—A drug used to treat diabetes, liraglutide, may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways.

Read more


Legalizing same-sex marriage increased health care access for gay men: Vanderbilt study

Jul. 11, 2018—One of the first studies to examine the health impacts of legal marriage for LGBT individuals has found gay men were more likely to receive routine medical care following marriage legalization.

Read more


Mom may pass bacteria to baby in utero: Study

Jul. 5, 2018—New findings by Jörn-Hendrik Weitkamp and colleagues provide the first account of bacterial signatures in mammalian fetal intestinal tissue. The results suggest that bacterial DNA moves from the mother’s microbiome into the fetal intestine, which may be a critical stimulus for normal mucosal immune development.

Read more


SMAD4 clue to colon cancer

Jul. 5, 2018—Chronic inflammation is a predisposing condition for colorectal cancer, the third leading cause of cancer-related deaths in the United States. Anna Means, Ph.D., and colleagues have now linked inflammation-driven carcinogenesis in the colon to loss of an important signaling protein called SMAD4.

Read more


Oak Ridge and Vanderbilt come together to explore cellular processes

Jul. 3, 2018—Vanderbilt and Oak Ridge National Laboratory are combining their expertise in biology, chemistry, physics, mathematics and computation to tackle some of the most pressing problems in biology.

Read more


Scavengers “protect” HDL

Jun. 29, 2018—Lipid molecules that bind to HDL can modify its function — and blocking that modification can protect HDL and potentially lower the risk of atherosclerosis and heart disease.

Read more


New staph virulence factor

Jun. 28, 2018—The new factor, an enzyme involved in host-pathogen interactions, may be a viable target for treating staph infections.

Read more


Shared genetics may shape treatment options for certain brain disorders

Jun. 14, 2018—Symptoms of schizophrenia and bipolar disorder, including psychosis, depression and manic behavior, have both shared and distinguishing genetic factors, an international consortium led by researchers from Vanderbilt University and Virginia Commonwealth University is reporting.

Read more


Novel infection fighter

Jun. 13, 2018—A drug in use clinically to help make vaccines more effective may be a powerful new tool for fighting antibiotic-resistant infections.

Read more


Confronting TB resistance

Jun. 11, 2018—Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis.

Read more


Upcoming Events

MORE EVENTS »